Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by scarlet1967

T.TH

RE:Next two ADC conferences

ADC conference in London, 2025! https://web.hansonwadegroup.com/rs/355-DOS...

1 day ago

T.TH

Next two ADC conferences

              ...

1 day ago

T.TH

RE:RE:World ADC 2024

One can be cautiously optimistic not only because of the language used but...

October 19, 2024

T.TH

World ADC 2024

https://web.hansonwadegroup.com/rs/355-DOS-429/images/World_ADC_San_Diego...

October 19, 2024

T.TH

The Triumph clinical trial

ClinicalTrials.gov ClinicalTrials.gov "The goal of this clinical...

October 14, 2024

T.TH

RE:RE:RE:RE:Question about Docetaxel & Th1902

Hi Lee, It was originally scheduled to have a part 4 handpicking patient who...

October 12, 2024

T.TH

RE:RE:Question about Docetaxel & Th1902

  Mannequin wrote: Hi Hamilton,  Well, we don't know...

October 12, 2024

T.TH

RE:Question on back up facility for Egrifta

"We do not own or operate manufacturing facilities for the production of...

October 12, 2024

T.TH

New article by the CMO

https://endpts.com/sp/pdcs-vs-adcs-a-new-frontier-in-targeted-cancer...

September 23, 2024

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:10years ago

How many times during the last decade have the investors been let down about...

September 17, 2024

T.TH

New article about Sort1 targeting PDC/potentially PDCs

  I don't have access to the full article. But what they are...

August 4, 2024

T.TH

RE:Do we have any anecdotal information?

My deepest condolences! PWIB123 wrote: I stepped away from paying much...

July 25, 2024

T.TH

Tesamorelin's therapeutic benefits for naive HIV patients

This is a recent study( Drs. Grinspoon, Fourman and Lindsay which all have...

July 16, 2024

T.TH

Rapid diagnosis

The main author Lindsay Fourman has researched and published many papers...

June 9, 2024

T.TH

RE:Drug conjugate compounds for stimulating the antitumor ...

The link. WO2024103161A1 - Drug conjugate compounds for stimulating the...

June 4, 2024

T.TH

Drug conjugate compounds for stimulating the antitumor ...

"Despite significant progresses made in the treatment of cancers with...

June 4, 2024

T.TH

Progression free survival rate

    This bispecific antibody stops immunosuppression and...

June 1, 2024

T.TH

RE:RE:RE:RE:RE:New Press Release - Theratechnologies' Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors

Apart from the clinical efficacy they are talking about and lower...

May 23, 2024

T.TH

Congratulations??

After a decade of dedicated leadership on our Board of Directors, Dawn...

May 13, 2024

T.TH

Leadership

"Leading followers astray is the mark of a false shepherd, who cares not...

May 10, 2024

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »